Oncogene 2011, 31:3002–3008 PubMedCrossRef

23 Ivanov SV,

Oncogene 2011, 31:3002–3008.PubMedCrossRef

23. Ivanov SV, Goparaju CM, Lopez PF-4708671 price P, Zavadil J, Toren-Haritan G, Rosenwald S, Hoshen M, Chajut A, Cohen D, Pass HI: Pro-tumorigenic effects of miR-31 loss in mesothelioma. J Biol Chem 2010, 285:22809–22817.PubMedCrossRef 24. Asangani IA, Harms PW, Dodson L, Pandhi M, Kunju LP, Maher CA, Fullen DR, Johnson TM, Giordano TJ, Palanisamy N: Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma. Oncotarget 2012, 3:1011–1025.PubMed 25. Augoff K, McCue B, Plow EF, Sossey-Alaoui K: miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer 2012, 11:5.PubMedCrossRef 26. Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, Matsuda Y, Sato-Otsubo A, Muto S, Utsunomiya A: Polycomb-mediated

loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers. Cancer Cell 2012, 21:121.PubMedCrossRef 27. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT: c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and Z-VAD-FMK datasheet glutamine metabolism. Nature 2009, 458:762–765.PubMedCrossRef 28. Rathore MG, Saumet A, Rossi J-F, De Bettignies C, Tempé D, Lecellier C-H, Villalba M: The NF-κB member p65 controls glutamine metabolism through miR-23a. Int J Biochem Cell Biol 2012, 44:1448–1456.PubMedCrossRef 29. Witt O, Deubzer HE, Milde T, Oehme I: HDAC family: what are the cancer relevant targets? Cancer Lett 2009, 277:8–21.PubMedCrossRef 30. Au SLK, Wong CCL, Lee JMF, Fan DNY, Tsang FH, Ng IOL, Wong CM: Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. Hepatology 2012, 56:622–631.PubMedCrossRef 31. Buurman R,

Gürlevik E, Schäffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F, Skawran B: Histone deacetylases activate hepatocyte growth factor signaling by repressing MicroRNA-449 in hepatocellular carcinoma cells. Gastroenterology 2012, 143:811–820. e815PubMedCrossRef 32. Cao Q, Mani R-S, Ateeq B, Dhanasekaran SM, Asangani this website IA, Prensner JR, Kim JH, Brenner JC, Jing X, Cao X: Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell 2011, 20:187–199.PubMedCrossRef 33. Bao B, Ali S, Banerjee S, Wang Z, Logna F, Azmi AS, Kong D, Ahmad A, Li Y, Padhye S: Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res 2012, 72:335–345.PubMedCrossRef 34. Mitra D, Das PM, Huynh FC, Jones FE: Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e. J Biol Chem 2011, 286:40531–40535.PubMedCrossRef 35.

Comments are closed.